Schedule 13G ownership disclosure

OnKure Therapeutics, Inc.

Common Stock · CUSIP: 68277Q105

Event date: 2024-12-31

Filing-level shares
706,733
Percent of class
5.58%
  • The Vanguard Group

    Shares: 706,733 · Class: 5.58%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000246
Form type
SCHEDULE 13G
Filer
OnKure Therapeutics, Inc.
CIK
CIK 1637715
Filed
Jan 31, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub